Developing a Point-of-Sale Health Communication Campaign for Cigarillos and Waterpipe Tobacco.


Journal

Health communication
ISSN: 1532-7027
Titre abrégé: Health Commun
Pays: England
ID NLM: 8908762

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 14 12 2017
medline: 26 5 2020
entrez: 14 12 2017
Statut: ppublish

Résumé

Adolescents and young adults smoke waterpipe tobacco (WT) and cigarillos, at least in part, based on erroneous beliefs that these products are safer than cigarettes. To address this challenge, we used a systematic, three-phase process to develop a health communication campaign to discourage WT and cigarillo smoking among at-risk (tobacco users and susceptible non-users) 16- to 25-year-olds. In Phase 1, we used a national phone survey (N = 896) to determine salient message beliefs. Participants reported constituents (i.e., harmful chemicals) emitted by the products were worrisome. In Phase 2, we developed and evaluated four message executions, with varying imagery, tone, and unappealing products with the same constituents, using focus groups (N = 38). Participants rated one execution highly, resulting in our development of a campaign where each message: (1) identified a tobacco product and constituent in the smoke; (2) included an image of an unappealing product containing the constituent (e.g., pesticides, gasoline) to grab attention; and (3) used a humorous sarcastic tone. In Phase 3, we tested the campaign messages (17 intervention and six control) with a nationally representative online survey (N = 1,636). Participants rated intervention and control messages highly with few differences between them. Exposure to messages resulted in significant increases in all risk beliefs from pre to post (p < 0.05). For WT, intervention messages increased beliefs about addiction more than control messages (p < 0.05). This systematic, iterative approach resulted in messages that show promise for discouraging WT and cigarillo use.

Identifiants

pubmed: 29236565
doi: 10.1080/10410236.2017.1407277
pmc: PMC6481293
mid: NIHMS1500424
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-351

Subventions

Organisme : NCI NIH HHS
ID : P50 CA180907
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001420
Pays : United States

Références

Nicotine Tob Res. 2007 Apr;9(4):473-81
pubmed: 17454702
MMWR Morb Mortal Wkly Rep. 2016 Jul 15;65(27):685-91
pubmed: 27416365
Nicotine Tob Res. 2016 May;18(5):827-33
pubmed: 26175458
Nicotine Tob Res. 2014 Mar;16(3):343-50
pubmed: 24151139
Drug Alcohol Depend. 2011 May 1;115(1-2):131-6
pubmed: 21353750
Tob Control. 2015 Mar;24 Suppl 1:i13-i21
pubmed: 25618895
Nicotine Tob Res. 2012 Apr;14(4):398-406
pubmed: 22039076
Nicotine Tob Res. 2016 May;18(5):817-26
pubmed: 26136525
Tob Control. 2016 Sep;26(5):592-599
pubmed: 27924009
MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7
pubmed: 27077789
Regul Toxicol Pharmacol. 2011 Nov;61(2):199-209
pubmed: 21821091
Nicotine Tob Res. 2015 Dec;17(12):1473-81
pubmed: 25634932
Health Place. 2015 Jul;34:63-6
pubmed: 25955537
Nicotine Tob Res. 2016 Jul;18(7):1566-74
pubmed: 26681775
Food Chem Toxicol. 2012 May;50(5):1494-8
pubmed: 22406330
Soc Sci Med. 2016 Sep;164:118-129
pubmed: 27423739
Tob Control. 2017 Jan;26(1):92-97
pubmed: 27165994
MMWR Morb Mortal Wkly Rep. 2014 Aug 1;63(30):650-4
pubmed: 25078654
Health Educ Behav. 2016 Jun;43(3):328-36
pubmed: 26304709
JAMA. 2000 Aug 9;284(6):735-40
pubmed: 10927783
J Health Commun. 2016 Jul;21(7):818-25
pubmed: 27337629
J Health Commun. 2013;18(3):354-68
pubmed: 23163605
Tob Control. 2013 May;22(e1):e51-6
pubmed: 22730446
J Behav Med. 2017 Apr;40(2):352-359
pubmed: 27663553
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
Int J Epidemiol. 2010 Jun;39(3):834-57
pubmed: 20207606
Am J Health Promot. 2009 Jan-Feb;23(3):195-202
pubmed: 19149425
Tob Control. 2016 May;25(3):341-54
pubmed: 25948713
Food Chem Toxicol. 2003 Jan;41(1):143-52
pubmed: 12453738
Am J Prev Med. 2008 Jul;35(1):14-9
pubmed: 18482819
Nicotine Tob Res. 2016 Jul;18(7):1581-7
pubmed: 26764259
J Health Commun. 2015 Aug;20(8):938-48
pubmed: 26054656
BMC Public Health. 2016 Jun 23;16:516
pubmed: 27333921
Health Psychol. 1996 Sep;15(5):355-61
pubmed: 8891714
BMC Public Health. 2015 Apr 24;15:390
pubmed: 25907101
J Health Commun. 2004 May-Jun;9(3):259-74
pubmed: 15360037

Auteurs

Erin L Sutfin (EL)

a Department of Social Sciences & Health Policy, Division of Public Health Sciences , Wake Forest School of Medicine.

Jennifer Cornacchione Ross (J)

a Department of Social Sciences & Health Policy, Division of Public Health Sciences , Wake Forest School of Medicine.

Allison J Lazard (AJ)

b School of Media and Journalism , University of North Carolina.

Elizabeth Orlan (E)

c Department of Health Behavior, Gillings School of Global Public Health , University of North Carolina.

Cynthia K Suerken (CK)

d Department of Biostatistical Sciences, Division of Public Health Sciences , Wake Forest School of Medicine.

Kimberly D Wiseman (KD)

a Department of Social Sciences & Health Policy, Division of Public Health Sciences , Wake Forest School of Medicine.

Beth A Reboussin (BA)

d Department of Biostatistical Sciences, Division of Public Health Sciences , Wake Forest School of Medicine.

Mark Wolfson (M)

a Department of Social Sciences & Health Policy, Division of Public Health Sciences , Wake Forest School of Medicine.
e Center for Research on Substance Use and Addiction , Wake Forest School of Medicine.

Seth M Noar (SM)

b School of Media and Journalism , University of North Carolina.
f Lineberger Comprehensive Cancer Center , University of North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH